Literature DB >> 24946948

Identification of human single-chain antibodies with broad reactivity for noroviruses.

Wanzhi Huang1, Moumita Samanta1, Sue E Crawford2, Mary K Estes3, Frederick H Neill2, Robert L Atmar3, Timothy Palzkill4.   

Abstract

Norovirus infections are a common cause of gastroenteritis and new methods to rapidly diagnose norovirus infections are needed. The goal of this study was to identify antibodies that have broad reactivity of binding to various genogroups of norovirus. A human scFv phage display library was used to identify two antibodies, HJT-R3-A9 and HJT-R3-F7, which bind to both genogroups I and II norovirus virus-like particles (VLPs). Mapping experiments indicated that the HJT-R3-A9 clone binds to the S-domain while the HJT-R3-F7 clone binds the P-domain of the VP1 capsid protein. In addition, a family of scFv antibodies was identified by elution of phage libraries from the GII.4 VLP target using a carbohydrate that serves as an attachment factor for norovirus on human cells. These antibodies were also found to recognize both GI and GII VLPs in enzyme-linked immunosorbent assay (ELISA) experiments. The HJT-R3-A9, HJT-R3-F7 and scFv antibodies identified with carbohydrate elution were shown to detect antigen from a clinical sample known to contain GII.4 norovirus but not a negative control sample. Finally, phages displaying the HJT-R3-A9 scFv can be used directly to detect both GI.1 and GII.4 norovirus from stool samples, which has the potential to simplify and reduce the cost of diagnostics based on antibody-based ELISA methods.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antibody library; diagnostics; norovirus; phage display; single-chain antibody

Mesh:

Substances:

Year:  2014        PMID: 24946948      PMCID: PMC4191442          DOI: 10.1093/protein/gzu023

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  53 in total

1.  Antibody arrays for high-throughput screening of antibody-antigen interactions.

Authors:  R M de Wildt; C R Mundy; B D Gorick; I M Tomlinson
Journal:  Nat Biotechnol       Date:  2000-09       Impact factor: 54.908

2.  Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens.

Authors:  Anne M Hutson; Robert L Atmar; Donald M Marcus; Mary K Estes
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Structural requirements for the assembly of Norwalk virus-like particles.

Authors:  Andrea Bertolotti-Ciarlet; Laura J White; Rong Chen; B V Venkataram Prasad; Mary K Estes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Rapid identification of small binding motifs with high-throughput phage display: discovery of peptidic antagonists of IGF-1 function.

Authors:  Kurt Deshayes; Michelle L Schaffer; Nicholas J Skelton; Gerald R Nakamura; Saloumeh Kadkhodayan; Sachdev S Sidhu
Journal:  Chem Biol       Date:  2002-04

Review 5.  Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses.

Authors:  R L Atmar; M K Estes
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

6.  Evaluation of a commercial ELISA for detecting Norwalk-like virus antigen in faeces.

Authors:  A F Richards; B Lopman; A Gunn; A Curry; D Ellis; H Cotterill; S Ratcliffe; M Jenkins; H Appleton; C I Gallimore; J J Gray; D W G Brown
Journal:  J Clin Virol       Date:  2003-01       Impact factor: 3.168

7.  Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP.

Authors:  Noritoshi Kitamoto; Tomoyuki Tanaka; Katsurou Natori; Naokazu Takeda; Shuji Nakata; Xi Jiang; Mary K Estes
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

8.  Precise characterization of norovirus (Norwalk-like virus)-specific monoclonal antibodies with broad reactivity.

Authors:  Tomoko Yoda; Yasuhiko Suzuki; Yoshitake Terano; Kenji Yamazaki; Naomi Sakon; Tsuyoshi Kuzuguchi; Hajime Oda; Teizo Tsukamoto
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

9.  Structural basis for the recognition of Lewis antigens by genogroup I norovirus.

Authors:  Tomomi Kubota; Akiko Kumagai; Hiromi Ito; Sanae Furukawa; Yuichi Someya; Naokazu Takeda; Koji Ishii; Takaji Wakita; Hisashi Narimatsu; Haruko Shirato
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

10.  Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.

Authors:  Lisa C Lindesmith; Martina Beltramello; Eric F Donaldson; Davide Corti; Jesica Swanstrom; Kari Debbink; Antonio Lanzavecchia; Ralph S Baric
Journal:  PLoS Pathog       Date:  2012-05-17       Impact factor: 6.823

View more
  14 in total

1.  Norovirus Antigen Detection with a Combination of Monoclonal and Single-Chain Antibodies.

Authors:  Baijun Kou; Wanzhi Huang; Frederick H Neill; Timothy Palzkill; Mary K Estes; Robert L Atmar
Journal:  J Clin Microbiol       Date:  2015-10-07       Impact factor: 5.948

2.  Characterization of cross-reactive norovirus-specific monoclonal antibodies.

Authors:  Baijun Kou; Sue E Crawford; Nadim J Ajami; Rita Czakó; Frederick H Neill; Tomoyuki N Tanaka; Noritoshi Kitamoto; Timothy G Palzkill; Mary K Estes; Robert L Atmar
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

3.  Deep sequencing of phage-displayed peptide libraries reveals sequence motif that detects norovirus.

Authors:  Amy M Hurwitz; Wanzhi Huang; Mary K Estes; Robert L Atmar; Timothy Palzkill
Journal:  Protein Eng Des Sel       Date:  2016-12-28       Impact factor: 1.650

4.  Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology.

Authors:  Leila Rahbarnia; Safar Farajnia; Hossein Babaei; Jafar Majidi; Bahman Akbari; Shiva Ahdi Khosroshahi
Journal:  Adv Pharm Bull       Date:  2016-12-22

5.  Deep Sequencing of a Systematic Peptide Library Reveals Conformationally-Constrained Protein Interface Peptides that Disrupt a Protein-Protein Interaction.

Authors:  David M Boragine; Wanzhi Huang; Lynn H Su; Timothy Palzkill
Journal:  Chembiochem       Date:  2021-12-07       Impact factor: 3.164

6.  High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing.

Authors:  Wanzhi Huang; Victoria Soeung; David M Boragine; Liya Hu; B V Venkataram Prasad; Mary K Estes; Robert L Atmar; Timothy Palzkill
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

Review 7.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

8.  Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding.

Authors:  Gopal Sapparapu; Rita Czakó; Gabriela Alvarado; Sreejesh Shanker; B V Venkataram Prasad; Robert L Atmar; Mary K Estes; James E Crowe
Journal:  PLoS Pathog       Date:  2016-06-29       Impact factor: 6.823

9.  A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.

Authors:  Yan Li; Yuhua Wan; Peipei Liu; Jincun Zhao; Guangwen Lu; Jianxun Qi; Qihui Wang; Xuancheng Lu; Ying Wu; Wenjun Liu; Buchang Zhang; Kwok-Yung Yuen; Stanley Perlman; George F Gao; Jinghua Yan
Journal:  Cell Res       Date:  2015-09-22       Impact factor: 25.617

10.  Llama nanoantibodies with therapeutic potential against human norovirus diarrhea.

Authors:  Lorena Garaicoechea; Andrea Aguilar; Gabriel I Parra; Marina Bok; Stanislav V Sosnovtsev; Gabriela Canziani; Kim Y Green; Karin Bok; Viviana Parreño
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.